Northern Trust’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.21M | Sell |
|
|||||
|
2025
Q2 | $3.45M | Sell |
|
|||||
|
2025
Q1 | $2.42M | Sell |
|
|||||
|
2024
Q4 | $3.23M | Buy |
|
|||||
|
2024
Q3 | $5.8M | Buy |
|
|||||
|
2024
Q2 | $2.85M | Sell |
|
|||||
|
2024
Q1 | $3.01M | Sell |
|
|||||
|
2023
Q4 | $2.65M | Buy |
|
|||||
|
2023
Q3 | $2.79M | Buy |
|
|||||
|
2023
Q2 | $3.11M | Buy |
|
|||||
|
2023
Q1 | $1.52M | Buy |
|
|||||
|
2022
Q4 | $2.37M | Buy |
|
|||||
|
2022
Q3 | $2.12M | Buy |
|
|||||
|
2022
Q2 | $1.6M | Buy |
|
|||||
|
2022
Q1 | $2.43M | Sell |
|
|||||
|
2021
Q4 | $3.7M | Buy |
|
|||||
|
2021
Q3 | $5.97M | Sell |
|
|||||
|
2021
Q2 | $6.6M | Buy |
|
|||||
|
2021
Q1 | $4.95M | Buy |
|
|||||
|
2020
Q4 | $4.36M | Sell |
|
|||||
|
2020
Q3 | $4.86M | Sell |
|
|||||
|
2020
Q2 | $4.72M | Buy |
|
|||||
|
2020
Q1 | $3.39M | Buy |
|
|||||
|
2019
Q4 | $3.56M | Buy |
|